cancer treatment resources for breast cancer, prostate cancer and other cancer informationcancer treatment resources for breast cancer, prostate cancer and other cancer information

breast cancer treatment clinical trials for breast cancer
 
  • GW572016 for Treatment of Refractory Metastatic Breast Cancer
     
  • Paclitaxel With or Without GW572016 as First Line Therapy for Women With Advanced or Metastatic Breast Cancer
     
  • Study Comparing GW572016 and Letrozole Versus Letrozole in Subjects With Advanced or Metastatic Breast Cancer
     
  • Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced or Metastatic Breast Cancer
     
  • GW572016, An Oral Drug For Women With Refractory Metastatic Breast Cancer After First-line Or Second-line Herceptin
     
  •  

    Modest Physical Activity Improves Survival in Breast Cancer Patients

    Articles
    Letrozole May Cut Risk of Breast Cancer
     
    Tesmilifene in Addition to Doxorubicin Improves Survival in Advanced Breast Cancer
     
    Doxil ® Plus Gemzar ® Active in Metastatic Breast Cancer
     
    Brachytherapy May Be Just As Effective and More Convenient than Whole Breast Radiation for Breast Cancer

    According to results recently presented at the 95th annual meeting of the American Association for Cancer Research, physical activity, even in modest amounts, appears to improve survival and decrease recurrences in patients diagnosed with breast cancer.

    Breast cancer claims the lives of approximately 40,000 women annually in the United States alone. Much time and effort is being invested by researchers to determine possible associations between environmental and/or genetic factors and the risk of diagnosis or death from breast cancer, so women may alter their lifestyles to reduce their risk, or undergo appropriate screening measures if they are considered to be at high risk. Diet and exercise are two areas of investigation that have demonstrated a link in the development of various cancers.

    Researchers from Brigham and Women’s Hospital and Harvard University recently conducted a clinical study to evaluate the effects of exercise on survival in women diagnosed with breast cancer. This study included nearly 2,300 women who were participants in the Nurses’ Health Study. All women had been diagnosed with stages I, II or III breast cancer between 1984 and 1996. The researchers included several variables of the patients in their study, including stage of diagnosis, obesity, etc, as well as exercise. Exercise was measured in metabolic equivalent task hours (met-hours) per week, beginning 2 years after diagnosis. One met is equivalent to the caloric requirements and energy expenditure of a person at rest – 3 met-hours is equivalent to one hour of walking. Patients were followed until either their death caused by breast cancer or June 2002.

    Data indicated that the risk of death was decreased with physical activity, whether the amount of physical activity was modest or more intense, compared with being sedentary. The risk of death from breast cancer was decreased by 19% in women who had 3 to 8.9 met-hours per week of exercise; 54% in women who had 9 to 14.9 met-hours per week of exercise; 42% in women who had 15 to 23.9 met-hours per week of exercise; and 29% in women who had 24 or more met-hours per week of exercise. In terms of walking, this translates into a 19% reduced risk of death with just one hour of walking per week, and a 54% reduced risk of death with just 3 hours of walking per week.

    The researchers concluded that mild to moderate amounts of physical activity following diagnosis significantly reduces the risk of death from breast cancer in women diagnosed with stages I-III breast cancer. Women who have been diagnosed with early breast cancer may wish to speak with their physician about the risks and benefits of different types of exercise and/or a specific exercise program.

    Reference: Holmes M, et al. Physical activity and survival after breast cancer diagnosis. Proceedings from the 95th annual meeting of the American Association for Cancer Research. March 2004. Abstract #1462.

    © CancerConsultants.com
     

    cancer treatment letrozole article
     
    cancer treatment bottom line breast and prostate cancer cancer treatment bottom line right breast cancer prostate
    Home :: Clinical Trials :: Cancer Info :: Breast Cancer :: About Us :: Sitemap
    cancer treatment bottom drop shadow
    cancer treatment home page resouces on breast cancer treatment cancer clinical trials information general cancer information and resources breast cancer awareness and treatment of breast cancer about cancer treatment .com